Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Citric acid monohydrate may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
Like all medicines, this medicine can cause side effects,
3. Further information
44! you accidentally take too much see a doctor straight
although not everybody gets them. Hypersensitivty/alergic away. Take the pack with you to show which medicine you reactions are possible with this product (frequency
have swallowed.
unknown).
*Do not use after theexpr date. The expiry date reters to
diarrhoea.
disposal.
IT taken excessively above the stated dose, glycerci present – tha tast day of that month
ITyou
notke any side effects, stop use and tell your doctor
r7 parma
They wil tell you what to do.
"
Reporting of side effects
ITyou gat any side effects, talkto your doctor, pharmacist of nurse. This Includes any passive side efiects not listed
In this leaflet. You can also report side effects directly Wa
ingredient
the Oy 125mg,
is:
per Sent is: citric acki rmonohydrate
The other ingredients are: aniseed flavour (contains
propylene glycol), glycerol (642). sucrose, sodium benzoate (E211) and purified water.
What the medicine looks like
the Yelow Card Scheme at www.rihra.gov.ukyellowcard = simple Linctus is a colourless syrupy liquid. of saarch for MHRA Yellow Card' In theGooge Play or
itis supplied In a 200m! bottie.
Apple App Store.
This label was last revised in July 2020.
reporting
site effects
you can hap provide more
whoration on the satety of thismadkine.
2774882007
The active substance in Simple Linctus BP is citric acid monohydrate.
Medicines with the same active substance, strength and form include: Simple Linctus Paediatric BP, Simple Linctus Paediatric Sugar Free, Simple Linctus Paediatric Sugar Free. In total there are 5 equivalent products. They are interchangeable only if your prescriber or pharmacist says so.
This leaflet reproduces the patient information leaflet approved for Simple Linctus BP, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
For relief of the symptoms of coughs.
Oral.
Recommended Doses
Adults, the elderly and children over 12 years: One 5ml spoonful, repeated up to four times per day.
Children under 12 years: Not recommended.
None Known.
Keep out of the reach of children.
Not suitable for children under 12 years.
This product contains 4g of sucrose per dose. To be taken into account in people with diabetes mellitus. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.
This medicine contains less than 1mmol sodium (23 mg) per 5ml dose, that is to say essentially 'sodium-free'. This medicine contains 2.5mg sodium benzoate per 5ml dose.
None known.
No adverse effects are known for the product, however, as with all medicines use should be avoided during pregnancy unless recommended by a doctor.
None known.
Tabulated list of adverse reaction(s)
Adverse reactions frequency are defined using the following convention:
Very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to < 1/1,000); very rare (< 1/10,000), not known (cannot be estimated from the available data).
System organ class (MedDRA)
Frequency
Adverse event
Immune System Disorders
Not known
Hypersensitivity
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Overdose with this preparation is unlikely to occur due to the low concentrations of the ingredients, however, in the event, treatment should be symptomatic.
Ask anything about Simple Linctus BP. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.